Annual Short Term Debt
$6.90 B
+$5.40 B+359.96%
31 December 2023
Summary:
Eli Lilly and Company annual short term debt is currently $6.90 billion, with the most recent change of +$5.40 billion (+359.96%) on 31 December 2023. During the last 3 years, it has risen by +$6.90 billion (+79262.07%). LLY annual short term debt is now at all-time high.LLY Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$2.07 B
-$3.09 B-59.81%
30 September 2024
Summary:
Eli Lilly and Company quarterly short term debt is currently $2.07 billion, with the most recent change of -$3.09 billion (-59.81%) on 30 September 2024. Over the past year, it has dropped by -$170.40 million (-7.59%). LLY quarterly short term debt is now -69.96% below its all-time high of $6.90 billion, reached on 31 December 2023.LLY Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +360.0% | -7.6% |
| 3 y3 years | +10000.0% | +32.7% |
| 5 y5 years | +526.4% | +32.7% |
LLY Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -70.0% | >+9999.0% |
| 5 y | 5 years | at high | >+9999.0% | -70.0% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -70.0% | >+9999.0% |
Eli Lilly And Company Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.07 B(-59.8%) |
| June 2024 | - | $5.16 B(+212.5%) |
| Mar 2024 | - | $1.65 B(-76.1%) |
| Dec 2023 | $6.90 B(+360.0%) | $6.90 B(+207.6%) |
| Sept 2023 | - | $2.24 B(+239.3%) |
| June 2023 | - | $661.60 M(>+9900.0%) |
| Mar 2023 | - | $3.10 M(-99.8%) |
| Dec 2022 | $1.50 B(-2.4%) | $1.50 B(-14.0%) |
| Sept 2022 | - | $1.74 B(-17.8%) |
| June 2022 | - | $2.12 B(+56.5%) |
| Mar 2022 | - | $1.36 B(-11.9%) |
| Dec 2021 | $1.54 B(>+9900.0%) | $1.54 B(-1.6%) |
| Sept 2021 | - | $1.56 B(-12.1%) |
| June 2021 | - | $1.78 B(>+9900.0%) |
| Mar 2021 | - | $4.90 M(-43.7%) |
| Dec 2020 | $8.70 M(-99.4%) | $8.70 M(-98.5%) |
| Sept 2020 | - | $587.50 M(-53.5%) |
| June 2020 | - | $1.26 B(-61.1%) |
| Mar 2020 | - | $3.25 B(+116.6%) |
| Dec 2019 | $1.50 B(+36.0%) | $1.50 B(-4.1%) |
| Sept 2019 | - | $1.56 B(-24.4%) |
| June 2019 | - | $2.07 B(-12.2%) |
| Mar 2019 | - | $2.35 B(+113.7%) |
| Dec 2018 | $1.10 B(-70.3%) | $1.10 B(+10.0%) |
| Sept 2018 | - | $1.00 B(-67.1%) |
| June 2018 | - | $3.05 B(+32.3%) |
| Mar 2018 | - | $2.30 B(-37.8%) |
| Dec 2017 | $3.71 B(+91.3%) | $3.71 B(+4.8%) |
| Sept 2017 | - | $3.54 B(+44.8%) |
| June 2017 | - | $2.44 B(-6.3%) |
| Mar 2017 | - | $2.61 B(+34.7%) |
| Dec 2016 | $1.94 B(>+9900.0%) | $1.94 B(+202.0%) |
| Sept 2016 | - | $641.50 M(-0.7%) |
| June 2016 | - | $645.80 M(-0.4%) |
| Mar 2016 | - | $648.30 M(>+9900.0%) |
| Dec 2015 | $6.10 M(-99.8%) | $6.10 M(-34.4%) |
| Sept 2015 | - | $9.30 M(-13.9%) |
| June 2015 | - | $10.80 M(-98.7%) |
| Mar 2015 | - | $805.40 M(-70.0%) |
| Dec 2014 | $2.69 B(+165.5%) | $2.69 B(+759.0%) |
| Sept 2014 | - | $313.00 M(+2938.8%) |
| June 2014 | - | $10.30 M(+13.2%) |
| Mar 2014 | - | $9.10 M(-99.1%) |
| Dec 2013 | $1.01 B(+8409.2%) | $1.01 B(-0.6%) |
| Sept 2013 | - | $1.02 B(-0.4%) |
| June 2013 | - | $1.02 B(-0.5%) |
| Mar 2013 | - | $1.03 B(+8538.7%) |
| Dec 2012 | $11.90 M(-99.2%) | $11.90 M(+30.8%) |
| Sept 2012 | - | $9.10 M(0.0%) |
| June 2012 | - | $9.10 M(-14.2%) |
| Mar 2012 | - | $10.60 M(-99.3%) |
| Dec 2011 | $1.52 B(+875.8%) | $1.52 B(-6.5%) |
| Sept 2011 | - | $1.63 B(+6.6%) |
| June 2011 | - | $1.53 B(-0.7%) |
| Mar 2011 | - | $1.54 B(+887.1%) |
| Dec 2010 | $156.00 M(+469.3%) | $156.00 M(+484.3%) |
| June 2010 | - | $26.70 M(+32.8%) |
| Mar 2010 | - | $20.10 M(-26.6%) |
| Dec 2009 | $27.40 M(-99.5%) | $27.40 M(-95.6%) |
| Sept 2009 | - | $622.50 M(-39.8%) |
| June 2009 | - | $1.03 B(-35.4%) |
| Mar 2009 | - | $1.60 B(-72.6%) |
| Dec 2008 | $5.85 B(+1313.2%) | $5.85 B(+1270.8%) |
| Sept 2008 | - | $426.50 M(+527.2%) |
| June 2008 | - | $68.00 M(-6.8%) |
| Mar 2008 | - | $73.00 M(-82.4%) |
| Dec 2007 | $413.70 M(+88.6%) | $413.70 M(-6.4%) |
| Sept 2007 | - | $442.10 M(-4.8%) |
| June 2007 | - | $464.20 M(-36.8%) |
| Mar 2007 | - | $734.00 M(+234.5%) |
| Dec 2006 | $219.40 M | $219.40 M(-34.4%) |
| Sept 2006 | - | $334.20 M(-54.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2006 | - | $738.60 M(+0.4%) |
| Mar 2006 | - | $736.00 M(+0.2%) |
| Dec 2005 | $734.70 M(-63.6%) | $734.70 M(+16.8%) |
| Sept 2005 | - | $629.10 M(+172.8%) |
| June 2005 | - | $230.60 M(-1.1%) |
| Mar 2005 | - | $233.10 M(-88.5%) |
| Dec 2004 | $2.02 B(+928.3%) | $2.02 B(+21.1%) |
| Sept 2004 | - | $1.67 B(+4.4%) |
| June 2004 | - | $1.60 B(+98.0%) |
| Mar 2004 | - | $807.10 M(+310.7%) |
| Dec 2003 | $196.50 M(-64.0%) | $196.50 M(-3.0%) |
| Sept 2003 | - | $202.50 M(+26.5%) |
| June 2003 | - | $160.10 M(-4.8%) |
| Mar 2003 | - | $168.10 M(-69.2%) |
| Dec 2002 | $545.40 M(+90.5%) | $545.40 M(-38.3%) |
| Sept 2002 | - | $884.30 M(+84.5%) |
| June 2002 | - | $479.40 M(+1.5%) |
| Mar 2002 | - | $472.40 M(+65.0%) |
| Dec 2001 | $286.30 M(+55.3%) | $286.30 M(-34.7%) |
| Sept 2001 | - | $438.40 M(+2.0%) |
| June 2001 | - | $430.00 M(-0.6%) |
| Mar 2001 | - | $432.50 M(+134.7%) |
| Dec 2000 | $184.30 M(-23.7%) | $184.30 M(+309.6%) |
| Sept 2000 | - | $45.00 M(-10.2%) |
| June 2000 | - | $50.10 M(-3.3%) |
| Mar 2000 | - | $51.80 M(-78.6%) |
| Dec 1999 | $241.50 M(+33.1%) | $241.50 M(-30.1%) |
| Sept 1999 | - | $345.70 M(-3.6%) |
| June 1999 | - | $358.70 M(+0.6%) |
| Mar 1999 | - | $356.70 M(+96.6%) |
| Dec 1998 | $181.40 M(-20.3%) | $181.40 M(-54.4%) |
| Sept 1998 | - | $397.40 M(+103.7%) |
| June 1998 | - | $195.10 M(-11.3%) |
| Mar 1998 | - | $220.00 M(-3.3%) |
| Dec 1997 | $227.60 M(-81.2%) | $227.60 M(-46.2%) |
| Sept 1997 | - | $423.40 M(-26.7%) |
| June 1997 | - | $578.00 M(-56.7%) |
| Mar 1997 | - | $1.33 B(+10.0%) |
| Dec 1996 | $1.21 B(-36.5%) | $1.21 B(-19.1%) |
| Sept 1996 | - | $1.50 B(-23.2%) |
| June 1996 | - | $1.95 B(-3.8%) |
| Mar 1996 | - | $2.03 B(+6.2%) |
| Dec 1995 | $1.91 B(-29.9%) | $1.91 B(-26.0%) |
| Sept 1995 | - | $2.58 B(-18.6%) |
| June 1995 | - | $3.17 B(-12.5%) |
| Mar 1995 | - | $3.62 B(+32.9%) |
| Dec 1994 | $2.72 B(+419.1%) | $2.72 B(+268.9%) |
| Sept 1994 | - | $738.50 M(+9.2%) |
| June 1994 | - | $676.30 M(-12.4%) |
| Mar 1994 | - | $772.00 M(+47.1%) |
| Dec 1993 | $524.80 M(-11.2%) | $524.80 M(+13.2%) |
| Sept 1993 | - | $463.60 M(-34.7%) |
| June 1993 | - | $709.70 M(-9.1%) |
| Mar 1993 | - | $780.80 M(+32.1%) |
| Dec 1992 | $591.20 M(-14.3%) | $591.20 M(-44.3%) |
| Sept 1992 | - | $1.06 B(+19.2%) |
| June 1992 | - | $889.90 M(+12.4%) |
| Mar 1992 | - | $791.90 M(+14.7%) |
| Dec 1991 | $690.20 M(-44.3%) | $690.20 M(+5.3%) |
| Sept 1991 | - | $655.60 M(-6.1%) |
| June 1991 | - | $698.10 M(+25.4%) |
| Mar 1991 | - | $556.50 M(-55.1%) |
| Dec 1990 | $1.24 B(+825.0%) | $1.24 B(-1.1%) |
| Sept 1990 | - | $1.25 B(+93.0%) |
| June 1990 | - | $649.30 M(+193.7%) |
| Mar 1990 | - | $221.10 M(+65.0%) |
| Dec 1989 | $134.00 M(+5.5%) | $134.00 M(-52.7%) |
| Sept 1989 | - | $283.30 M(+19.8%) |
| June 1989 | - | $236.50 M(+86.2%) |
| Dec 1988 | $127.00 M(-46.7%) | $127.00 M(-46.7%) |
| Dec 1987 | $238.20 M(+3.2%) | $238.20 M(+3.2%) |
| Dec 1986 | $230.90 M | $230.90 M |
FAQ
- What is Eli Lilly and Company annual short term debt?
- What is the all time high annual short term debt for Eli Lilly and Company?
- What is Eli Lilly and Company annual short term debt year-on-year change?
- What is Eli Lilly and Company quarterly short term debt?
- What is the all time high quarterly short term debt for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly short term debt year-on-year change?
What is Eli Lilly and Company annual short term debt?
The current annual short term debt of LLY is $6.90 B
What is the all time high annual short term debt for Eli Lilly and Company?
Eli Lilly and Company all-time high annual short term debt is $6.90 B
What is Eli Lilly and Company annual short term debt year-on-year change?
Over the past year, LLY annual short term debt has changed by +$5.40 B (+359.96%)
What is Eli Lilly and Company quarterly short term debt?
The current quarterly short term debt of LLY is $2.07 B
What is the all time high quarterly short term debt for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly short term debt is $6.90 B
What is Eli Lilly and Company quarterly short term debt year-on-year change?
Over the past year, LLY quarterly short term debt has changed by -$170.40 M (-7.59%)